Search for Clinical Trial Results
Pulmonary Eosinophilia - 23 Studies Found
Status | Study |
Recruiting |
Study Name: Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients Condition: Asthma Date: 2015-09-17 Interventions:
|
Completed |
Study Name: Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control Condition: Asthma Date: 2014-10-30 Interventions:
|
Active, not recruiting |
Study Name: Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients Condition: Asthma Date: 2016-01-11 Interventions:
|
Recruiting |
Study Name: A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma Condition: Eosinophils, Asthma Date: 2017-02-07 Interventions: Drug: reslizumab 110-mg |
Completed |
Study Name: Efficacy, Safety, and Tolerability of SAR231893 (REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma Condition: Asthma Date: 2011-03-09 Interventions:
|
Enrolling by invitation |
Study Name: Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma Condition:
Date: 2015-09-22 Interventions:
|
Recruiting |
Study Name: Study of Mepolizumab Autoinjector in Asthmatics Condition: Asthma Date: 2017-03-29 Interventions: Drug: Mepolizumab It is a clear to opalescent, colorless to pale yellow sterile solution for SC injectio |
Active, not recruiting |
Study Name: Study of Mepolizumab Safety Syringe in Asthmatics Condition: Asthma Date: 2017-01-12 Interventions: Drug: Mepolizumab It is a clear to opalescent, colorless to pale yellow sterile solution for SC injectio |
Active, not recruiting |
Study Name: Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children Condition: Asthma Date: 2015-02-26 Interventions: Drug: Mepolizumab Mepolizumab is supplied as 100 mg lyophilised cake in sterile vials for subcutaneous a |
Recruiting |
Study Name: An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation Condition: Asthma Date: 2016-10-14 Interventions:
|